Immunochemotherapy with rituximab, vincristine and 5-day cyclophosphamide for heavily pretreated follicular lymphoma.

Mario Lazzarino,Luca Arcaini,Ester Orlandi,Isabella Iacona,Paolo Bernasconi,Silvia Calatroni,Marzia Varettoni,Luciano Isa,Ercole Brusamolino,Maurizio Bonfichi,Francesco Passamonti,Sara Burcheri,Cristiana Pascutto,Mario Regazzi

Immunochemotherapy with rituximab, vincristine and 5-day cyclophosphamide for heavily pretreated follicular lymphoma.

2005

Mario Lazzarino
Luca Arcaini
Ester Orlandi
Isabella Iacona
Paolo Bernasconi
Silvia Calatroni
Marzia Varettoni
Luciano Isa
Ercole Brusamolino
Maurizio Bonfichi
Francesco Passamonti
Sara Burcheri
Cristiana Pascutto
Mario Regazzi

Purpose: Therapeutic options for relapsed or refractory follicular lymphoma include combination chemotherapy, immunotherapy and, for selected patients, autotransplant. Because of th

Keywords:

Follicular lymphoma
Pathology
Lymphoma
Immunology
Vincristine
Rituximab
Medicine
Refractory Follicular Lymphoma
Nitrogen mustard
Chemotherapy
Cyclophosphamide
combination chemotherapy
Regimen

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations